These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11879287)

  • 1. Epirubicin as adjuvant therapy for breast cancer.
    Suh C
    Cancer Pract; 2001; 9(2):104-6. PubMed ID: 11879287
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.
    Pacchiarotti I; Mazzarini L; Pellegrini P; Venturelli V; Sani G; Sánchez-Moreno J; Mancinelli I; Tatarelli R; Kotzalidis GD; Girardi P
    Gen Hosp Psychiatry; 2007; 29(5):461-3. PubMed ID: 17888816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin for adjuvant therapy in node-positive breast cancer.
    Med Lett Drugs Ther; 2000 Feb; 42(1071):12-3. PubMed ID: 10725968
    [No Abstract]   [Full Text] [Related]  

  • 4. A phase II trial of high dose epirubicin in patients with advanced breast carcinoma.
    Miller DK; Munshi N; Loesch D; Einhorn LE; Sledge GW
    Cancer; 2000 Jan; 88(2):375-80. PubMed ID: 10640971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epirubicin: is it like doxorubicin in breast cancer? A clinical review.
    Khasraw M; Bell R; Dang C
    Breast; 2012 Apr; 21(2):142-9. PubMed ID: 22260846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epirubicin: a review of its efficacy as adjuvant therapy and in the treatment of metastatic disease in breast cancer.
    Ormrod D; Holm K; Goa K; Spencer C
    Drugs Aging; 1999 Nov; 15(5):389-416. PubMed ID: 10600046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer.
    Yeo W; Mok TS; Tse KK; Kwan WH; Lam KC; Ho WM; Chiu SK; Chan AT; Leung TW; Mo FK; Johnson PJ
    Anticancer Drugs; 2002 Jul; 13(6):655-62. PubMed ID: 12172512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Images in clinical medicine. Extravasation of epirubicin.
    Vano-Galvan S; Jaen P
    N Engl J Med; 2009 May; 360(20):2117. PubMed ID: 19439746
    [No Abstract]   [Full Text] [Related]  

  • 9. Epirubicin in breast cancer: present and future.
    Levine M
    Clin Breast Cancer; 2000 Sep; 1 Suppl 1():S62-7. PubMed ID: 11970752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques.
    Meinardi MT; Van Der Graaf WT; Gietema JA; Van Den Berg MP; Sleijfer DT; De Vries EG; Haaksma J; Boomsma F; Van Veldhuisen DJ
    Heart; 2002 Jul; 88(1):81-2. PubMed ID: 12067953
    [No Abstract]   [Full Text] [Related]  

  • 11. Sino-atrial block during anesthesia in a patient with breast cancer being treated with the anticancer drug epirubicin.
    Okamoto T; Ogata J; Minami K
    Anesth Analg; 2003 Jul; 97(1):19-20, table of contents. PubMed ID: 12818936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polychemotherapy versus monotherapy in metastatic breast carcinoma].
    Tanner J; Dunst J
    Strahlenther Onkol; 1999 Sep; 175(9):471. PubMed ID: 10518983
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of epirubicin in advanced breast cancer.
    Conte PF; Gennari A; Landucci E; Orlandini C
    Clin Breast Cancer; 2000 Sep; 1 Suppl 1():S46-51. PubMed ID: 11970749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anthracycline induced cardiomyopathy in 51-years old women with breast cancer].
    Biskup P; Wozakowska-Kapłon B; Góźdź S
    Pol Arch Med Wewn; 2006 Jun; 115(6):551-8. PubMed ID: 17263227
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results.
    Ventura GJ
    J Clin Oncol; 2005 Apr; 23(12):2873; author reply 2873-4. PubMed ID: 15838014
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy during pregnancy: what is really safe?
    Peccatori F; Martinelli G; Gentilini O; Goldhirsch A
    Lancet Oncol; 2004 Jul; 5(7):398. PubMed ID: 15231245
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of epirubicin adjuvant chemotherapy in a breast cancer patient with chronic renal failure undergoing hemodialytic treatment.
    Gori S; Rulli A; Mosconi AM; Sidoni A; Colozza M; Crinò L
    Tumori; 2006; 92(4):364-5. PubMed ID: 17036534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe adverse reaction to high dose epirubicin and cyclophosphamide for poor prognosis breast cancer.
    Turtle CJ; Keefe DM; Bell D; Wheeler H; Ma DD
    Aust N Z J Med; 1999 Apr; 29(2):275-7. PubMed ID: 10342033
    [No Abstract]   [Full Text] [Related]  

  • 19. Epirubicin as adjuvant therapy in breast cancer.
    Earl H; Iddawela M
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):189-95. PubMed ID: 15056049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose epirubicin in locally advanced operable noninflammatory breast cancer: a feasibility trial.
    Crivellari D; Buonadonna A; Sacco C; Bidoli E; Candiani E; Massarut S; Roncadin M; Rossi C; Galligioni E
    Tumori; 1997; 83(3):656-60. PubMed ID: 9267483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.